Literature DB >> 15966244

Regression of EI2-stage low-grade gastric MALT-lymphoma after H. pylori eradication.

Giovanni Cammarota1, Paolo Fedeli, Antonio Bianchi, Rossella Cianci, Antonio Martino, Giuseppe Fedeli, Giovanni Gasbarrini.   

Abstract

To our knowledge there are only a few reports showing a role of eradication therapy for H. pylori in the treatment of low-grade MALT-lymphoma, of stage EI2. We report a rare case of MALT-lymphoma, invading all of the gastric wall, which regressed after eradication of H. pylori. The regression was well documented by endoscopic ultrasonography (EUS). A 70-year-old man was referred to us for upper endoscopy that showed a single ulcer of 3cm in diameter at the gastric angulus. Histology, immunohistochemistry and PCR analyses diagnosed a low-grade MALT-lymphoma in the presence of H. pylori infection. EUS showed a tumor invasion of all the gastric wall. The serosa layer, also, appeared irregular and interrupted in some points. The lymph nodes around the duodenum and the stomach were not involved. An anti-H. pylori therapy was started. After 1 year from the diagnosis, EUS showed the reappearance of the normal layers of the stomach. The patient is actually disease free. This result suggests that in EI2-stage gastric lymphoma of MALT type, in the absence of both high-grade malignancy foci and t(11;18)(q21;q21) chromosomal translocation, an eradication treatment may be considered as a first therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15966244

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  1 in total

Review 1.  The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer.

Authors:  Rossella Cianci; Laura Franza; Giovanni Schinzari; Ernesto Rossi; Gianluca Ianiro; Giampaolo Tortora; Antonio Gasbarrini; Giovanni Gambassi; Giovanni Cammarota
Journal:  Int J Mol Sci       Date:  2019-01-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.